These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 1228241)

  • 1. Proceedings: Antigenicities of two fragments of Clostridium botulinum type B derivative toxin.
    Kozaki S; Sakaguchi G
    Jpn J Med Sci Biol; 1975; 28(5-6):323-6. PubMed ID: 1228241
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemiluminescence immunosorbent assay (CLISA) and a possibility of the specific detection of soluble antigens of Clostridium botulinum type A.
    Ligieza J; Reiss J; Michalik M
    Arch Immunol Ther Exp (Warsz); 1994; 42(2):129-33. PubMed ID: 7503646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proceedings: Further studies on the characterization of crystalline type A toxin of Clostridium botulinum.
    Schantz EJ; Gasper E
    Jpn J Med Sci Biol; 1975 Feb; 28(1):66-9. PubMed ID: 240052
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antigenic variations in F type botulinum toxins. Attempted definitions by serological typing and classification of Clostridium botulinum].
    Gimenez DF; Ciccarelli AS
    Medicina (B Aires); 1972; 32(6):596-606. PubMed ID: 4576316
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: Clostridium botulinum type A, B, E and F 12S toxins.
    Kozaki S; Sugii S; Oishi I; Sakaguchi S; Sakaguchi G
    Jpn J Med Sci Biol; 1975 Feb; 28(1):70-2. PubMed ID: 1099283
    [No Abstract]   [Full Text] [Related]  

  • 6. [Identification of strain B 657 of Clostridium botulinum].
    Giménez DF; Giménez JA
    Rev Argent Microbiol; 1983; 15(1):51-5. PubMed ID: 6400761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of Clostridium botulinum type B derivative toxin: inhibition with a fragment of toxin from binding to synaptosomal fraction [proceedings].
    Kozaki S; Miyazaki S; Sakaguchi G
    Jpn J Med Sci Biol; 1978 Apr; 31(2):163-6. PubMed ID: 79664
    [No Abstract]   [Full Text] [Related]  

  • 8. Determination of soluble antigens of Clostridium botulinum A by chemiluminescent--immunosorbent assay (CLISA).
    Ligieza J; Michalik M; Reiss J; Grzybowski J
    Arch Immunol Ther Exp (Warsz); 1986; 34(2):189-95. PubMed ID: 2431667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proceedings: Immunological specificities of Clostridium botulinum type C and D toxins.
    Shimizu T; Izumi N; Kondo H
    Jpn J Med Sci Biol; 1975; 28(5-6):298-301. PubMed ID: 1228237
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro assays for botulinum toxin and antitoxins.
    Shone C; Appleton N; Wilton-Smith P; Hambleton P; Modi N; Gatley S; Melling J
    Dev Biol Stand; 1986; 64():141-5. PubMed ID: 3792644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of antitoxin with each of two complementary fragments of Clostridium botulinum type B derivative toxin.
    Kozaki S; Miyazaki S; Sakaguchi G
    Infect Immun; 1977 Dec; 18(3):761-6. PubMed ID: 412790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of type A, B, E, and F Clostridium botulinum neurotoxins in foods by using an amplified enzyme-linked immunosorbent assay with digoxigenin-labeled antibodies.
    Sharma SK; Ferreira JL; Eblen BS; Whiting RC
    Appl Environ Microbiol; 2006 Feb; 72(2):1231-8. PubMed ID: 16461671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The detection and prevalence of Clostridium botulinum in pig intestinal samples.
    Myllykoski J; Nevas M; Lindström M; Korkeala H
    Int J Food Microbiol; 2006 Jul; 110(2):172-7. PubMed ID: 16806550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separation of Clostridium botulinum type A derivative toxin into two fragments.
    Kozaki S; Togashi S; Sakaguchi G
    Jpn J Med Sci Biol; 1981 Apr; 34(2):61-8. PubMed ID: 7311108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antigenicity of Clostridium botulinum type C toxin administered per os.
    Jansen BC; Knoetze PC; Visser F
    Onderstepoort J Vet Res; 1970 Sep; 37(3):169-71. PubMed ID: 4949136
    [No Abstract]   [Full Text] [Related]  

  • 16. [Amino acid composition of major components of Cl. botulinum toxin of type B].
    Kliucheva VV; Saprykina TP; Dolgikh MS; Blagoveshchenskiĭ VA
    Vopr Med Khim; 1982; 28(5):29-33. PubMed ID: 6758340
    [No Abstract]   [Full Text] [Related]  

  • 17. Toxin occurrence time in relation to sensorial changes in meat cans contaminated with Clostridium botulinum type B endospores.
    Palec W
    Acta Microbiol Pol; 1996; 45(1):75-83. PubMed ID: 8795258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clostridium botulinum in Costa Rica soils].
    Gamboa MM; Rodríguez E; Fernández B
    Rev Biol Trop; 1993 Dec; 41(3A):359-63. PubMed ID: 7701075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-time PCR detection of the nontoxic nonhemagglutinin gene as a rapid screening method for bacterial isolates harboring the botulinum neurotoxin (A-G) gene complex.
    Raphael BH; Andreadis JD
    J Microbiol Methods; 2007 Dec; 71(3):343-6. PubMed ID: 17961766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of botulinum toxin type by the reaction of indirect hemagglutination inhibition.
    Reiss J; Wojtyła B
    Arch Immunol Ther Exp (Warsz); 1981; 29(1):97-108. PubMed ID: 7025794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.